DiaMedica Therapeutics (DMAC) Change in Receivables (2018 - 2026)
DiaMedica Therapeutics (DMAC) reported Change in Receivables of $43000.0 for Q1 2026, up 152.94% on a YoY basis from $17000.0 in Q1 2025, and up 2250.0% quarter-over-quarter from -$2000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Change in Receivables (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics has reported Change in Receivables for 9 years, with the latest figure at $43000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 152.94% year-over-year to $43000.0; the trailing twelve-month figure through Mar 2026 stood at $48000.0 (up 132.88% YoY), and the FY2025 full-year result was $22000.0, up 116.54% from the prior year.
- Change in Receivables for Q1 2026 stood at $43000.0, up from -$2000.0 in the prior quarter.
- The five-year high for Change in Receivables was $131000.0 in Q2 2023, with the low at -$101000.0 in Q3 2024.
- Historically, Change in Receivables has averaged $10058.8 across 5 years, with a median of $7000.0 in 2022.
- Annual changes were most pronounced in 2022 — Change in Receivables soared 1366.67% — and 2025, when it tumbled 1050.0%.
- DiaMedica Therapeutics' Change in Receivables stood at $7000.0 in 2022, then soared by 742.86% to $59000.0 in 2023, then tumbled by 191.53% to -$54000.0 in 2024, then jumped by 96.3% to -$2000.0 in 2025, then surged by 2250.0% to $43000.0 in 2026.
- The last three Change in Receivables figures came in at $43000.0 (Q1 2026), -$2000.0 (Q4 2025), and $99000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -4.08 Mn |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - | 43,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43,000.00 |
| Mar 31, 2026 | 43,000.00 |
| Dec 31, 2025 | -2,000.00 |
| Dec 31, 2025 | -2,000.00 |
| Sep 30, 2025 | 99,000.00 |
| Sep 30, 2025 | 99,000.00 |
| Jun 30, 2025 | -92,000.00 |
| Jun 30, 2025 | -92,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Dec 31, 2024 | -54,000.00 |
| Dec 31, 2024 | -54,000.00 |
| Sep 30, 2024 | -101,000.00 |
| Sep 30, 2024 | -101,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Mar 31, 2024 | 30,000.00 |
| Mar 31, 2024 | 30,000.00 |
| Dec 31, 2023 | 59,000.00 |
| Dec 31, 2023 | 59,000.00 |